Dr Reddys Stock Today

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;padding-top: 25px;;'>DR</div>
Dr Reddys is trading at 52.01 as of the 12th of July 2020; that is 0.23% increase since the beginning of the trading day. The stock's open price was 51.89. Dr Reddys has less than a 12 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 30 trading days. Equity ratings for Dr Reddys Laboratories are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 13th of April 2020 and ending today, the 12th of July 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores

3 100 

   Odds of Distress

Dr Reddys Profile

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. The company was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on BATS Exchange. It employs 21650 people. more on Dr Reddys
Legal NameDr Reddys Laboratories
Thematic Classification
Currently Active Investing Idea
View All
Average Analyst Recommendation
Current trade recommendation based on an ongoing consensus estimate among financial analysis covering Dr Reddys Laboratories. The Dr Reddys consensus assessment is calculated by taking the average estimates from all of the analysts covering Dr Reddys
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Dr Reddys available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
Strong BuyFairly Valued
Dr Reddys Laboratories (RDY) is traded on BATS Exchange in USA and employs 21,650 people. The company currently falls under 'Mid-Cap' category with total capitalization of 8.58 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Dr Reddys's market, we take the total number of its shares issued and multiply it by Dr Reddys's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Dr Reddys Laboratories runs under Healthcare sector within Drug Manufacturers?Specialty & Generic industry. The entity has 165.84 M outstanding shares of which 1.44 M shares are at this time shorted by investors with about 6.48 days to cover shorted positions. DR. REDDY'S LAB L has about 283.41 M in cash with 75.58 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71.
Check Dr Reddys Probability Of Bankruptcy

Ownership Allocation (%)

Dr Reddys Stock Price Odds Analysis

Odds Down 52.01HorizonTargetOdds Up 52.01
58.66%30 days
Based on a normal probability distribution, the odds of Dr Reddys to move above the current price in 30 days from now is about 41.01 (This Dr Reddys Laboratories probability density function shows the probability of Dr Reddys Stock to fall within a particular range of prices over 30 days) .

Dr Reddys Laboratories Risk Profiles

Dr Reddys Stock Against Markets

Did you try this?

Run Pair Correlation Now


Pair Correlation

Compare performance and examine fundamental relationship between any two equity instruments
All  Next Launch Module

Dr Reddys Distributions to stockholders

A dividend is the distribution of a portion of Dr Reddys earnings, decided and managed by the Dr Reddyss board of directors and paid to a class of its shareholders. Note, announcements of dividend payouts are generally accompanied by a proportional increase or decrease in a company's stock price. Dr Reddys dividend payments follow a chronological order of events, and the associated dates are important to determine the shareholders who qualify for receiving the dividend payment.
10th of July 2020
12th of July 2019
13th of July 2018

Dr Reddys Corporate Directors

Hans Hasler Additional Independent Director
Leo Puri Non-Executive Independent Director
Ravi Bhoothalingam Non-Executive Independent Director
Additionally, take a look at Your Equity Center. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page